DrugPatentWatch Database Preview
Arbor Pharms Llc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for ARBOR PHARMS LLC, and when can generic versions of ARBOR PHARMS LLC drugs launch?
ARBOR PHARMS LLC has twenty-three approved drugs.
There are twenty-three US patents protecting ARBOR PHARMS LLC drugs.
There are three hundred and eleven patent family members on ARBOR PHARMS LLC drugs in forty-six countries and thirty-two supplementary protection certificates in seventeen countries.
Summary for Arbor Pharms Llc
| International Patents: | 311 |
| US Patents: | 23 |
| Tradenames: | 24 |
| Ingredients: | 15 |
| NDAs: | 23 |
Drugs and US Patents for Arbor Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-003 | Mar 29, 1982 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Arbor Pharms Llc | SOTYLIZE | sotalol hydrochloride | SOLUTION;ORAL | 205108-001 | Oct 22, 2014 | RX | Yes | Yes | 9,724,297 | Start Trial | Y | Start Trial | |||
| Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | RX | Yes | Yes | 8,791,153 | Start Trial | Y | Start Trial | |||
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | 8,795,725 | Start Trial | Y | Start Trial | |||
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | 8,686,034 | Start Trial | Start Trial | ||||
| Arbor Pharms Llc | E.E.S. | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Arbor Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-001 | Dec 20, 2011 | 5,736,555 | Start Trial |
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-001 | Feb 25, 2011 | 5,736,555 | Start Trial |
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | 4,757,128 | Start Trial |
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-001 | Feb 25, 2011 | 5,583,141 | Start Trial |
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-002 | Feb 25, 2011 | 5,736,555 | Start Trial |
| Arbor Pharms Llc | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | 4,868,179 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Lotion | 0.5% | ➤ Subscribe | 2017-09-01 |
International Patents for Arbor Pharms Llc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 1404324 | Start Trial |
| Japan | 5419169 | Start Trial |
| Argentina | 047972 | Start Trial |
| Norway | 20062112 | Start Trial |
| Taiwan | 200530227 | Start Trial |
| South Korea | 100926921 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Arbor Pharms Llc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1718641 | 132012902056823 | Italy | Start Trial | PRODUCT NAME: AZILSARTAN MEDOXOMIL(EDARBI E IPREZIV); AUTHORISATION NUMBER(S) AND DATE(S): EDARBI: DA EU/1/11/734/001 A EU/1/11/734/011; IPREZIV: DA EU/1/11/735/001 A EU/1/11/735/011, 20111207 |
| 1620113 | 56/2015 | Austria | Start Trial | PRODUCT NAME: IVERMECTIN; NAT. REGISTRATION NO/DATE: 136170 20150602; FIRST REGISTRATION: MT MA 117/01101 20150402 |
| 0260415 | SPC/GB01/013 | United Kingdom | Start Trial | PRODUCT NAME: N,N'-BIS(2-CHLOROETHYL)-N-NITROSO-UREA (CARMUSTINE) COMBINED WITH A POLYANHYDRIDE HAVING A WEIGHT AVERAGE MOLECULAR WEIGHT OF GREATER THAN 20,000 PREPARED BY THE POLYCONDENSATION OF: (I) 4,4'-(TRIMETHYLENEDIOXY)-DIBENZOIC ACID; AND (II) SEBACIC ACID (POLI; REGISTERED: FR 561 907-5 19990105; UK PL 00012/0337 20000928 |
| 1718641 | PA2012004,C1718641 | Lithuania | Start Trial | PRODUCT NAME: AZILSARTANUM MEDOXOMILUM; REGISTRATION NO/DATE: EU/1/11/734/001 - EU/1/11/734/011, 2011 12 07, EU/1/11/735/001 - EU/1/11/735/011 20111207 |
| 1620113 | C01620113/01 | Switzerland | Start Trial | PRODUCT NAME: IVERMECTINUM; REGISTRATION NO/DATE: AUTORISATION SWISSMEDIC 65561 20.12.2016 |
| 1718641 | C20120004 00052 | Estonia | Start Trial | PRODUCT NAME: EDARBI - ASILSARTAANMEDOKSOMIIL;REG NO/DATE: C(2011) 9280 FINAL 07.12.2011 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
